Exosomes Derived from BMMSCs Mitigate the Hepatic Fibrosis via Anti-Pyroptosis Pathway in a Cirrhosis Model

Researchers increasingly report the therapeutic effect of exosomes derived from rat bone marrow mesenchymal stem cells (Exos-rBMMSC) on liver disease, while the optimal dose of Exos-rBMMSC in liver cirrhotic treatment has not been reported. In this study, we aimed to explore the efficacy and dose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yichi, Zhangdi, Hanjing, Nie, Xinsheng, Wang, Lijuan, Wan, Zhuzhi, Jin, Hao, Pu, Ronghui, Liang, Meihui, Chang, Yuan, Gao, Yang, Zhang, Hailong, Jin, Shizhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776579/
https://www.ncbi.nlm.nih.gov/pubmed/36552767
http://dx.doi.org/10.3390/cells11244004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776579/
https://www.ncbi.nlm.nih.gov/pubmed/36552767
http://dx.doi.org/10.3390/cells11244004

Ejemplares similares